ASPG and neoplasm: Similar to L-asparaginase, arginine-depleting enzyme, arginine deiminase (ADI), is being used in multiple clinical trials for solid tumors based on the observation that certain types of tumor lack the expression of arginine biosynthetic enzymes and are thus arginine auxotrophic [68].